{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:25:25Z","timestamp":1782181525824,"version":"3.54.5"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>In recent decades, the world has gained experience of the dangerous effects of\npandemic events caused by emerging respiratory viruses. In particular, annual epidemics\nof influenza are responsible for severe illness and deaths. Even if conventional influenza\nvaccines represent the most effective tool for preventing virus infections, they are not\ncompletely effective in patients with severe chronic disease and immunocompromised and\nnew small molecules have emerged to prevent and control the influenza viruses. Thus, the\nattention of chemists is continuously focused on the synthesis of new antiviral drugs able\nto interact with the different molecular targets involved in the virus replication cycle. To\ndate, different classes of influenza viruses inhibitors able to target neuraminidase enzyme,\nhemagglutinin protein, Matrix-2 (M2) protein ion channel, nucleoprotein or RNAdependent\nRNA polymerase have been synthesized using several synthetic strategies\ncomprising the chemical modification of currently used drugs. The best results, in terms\nof inhibitory activity, are in the nanomolar range and have been obtained from the chemical\nmodification of clinically used drugs such as Peramivir, Zanamivir, Oseltamir,\nRimantadine, as well as sialylated molecules, and hydroxypyridinone derivatives. The aim\nof this review is to report, covering the period 2016-2022, the most recent routes related to\nthe synthesis of effective influenza virus inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230907093501","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:23:21Z","timestamp":1694406201000},"page":"2507-2549","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiviral Compounds to Address Influenza Pandemics: An Update\nfrom 2016-2022"],"prefix":"10.2174","volume":"31","author":[{"given":"Roberto","family":"Romeo","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, Universit\u00e0 di Messina, Viale\nF. Stagno D\u2019Alcontres, Messina, 98166, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Legnani","sequence":"additional","affiliation":[{"name":"Dipartimento di Biotecnologie e Bioscienze, Universit\u00e0 di\nMilano-Bicocca, Piazza della Scienza 2, Milano, 20126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Assunta","family":"Chiacchio","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze del Farmaco e della\nSalute, Universit\u00e0 di Catania, Viale A. Doria 6, Catania, 95125, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore V.","family":"Giofr\u00e8","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, Universit\u00e0 di Messina, Viale\nF. Stagno D\u2019Alcontres, Messina, 98166, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-0035","authenticated-orcid":true,"given":"Daniela","family":"Iannazzo","sequence":"additional","affiliation":[{"name":"Dipartimento di Ingegneria, Universit\u00e0\ndi Messina, Contrada di Dio, Messina, 98166, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"Hu B.","year":"2021","unstructured":"Hu B.; Guo H.; Zhou P.; Shi Z.L.; Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol  2021,19(3),141-154","journal-title":"Nat Rev Microbiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"Krammer F.","year":"2018","unstructured":"Krammer F.; Smith G.J.D.; Fouchier R.A.M.; Peiris M.; Kedzierska K.; Doherty P.C.; Palese P.; Shaw M.L.; Treanor J.; Webster R.G.; Garc\u00eda-Sastre A.; Influenza. Nat Rev Dis Primer  2018,4,3","journal-title":"Nat Rev Dis Primer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/21645515.2017.1348442","volume":"14","author":"Dini G.","year":"2018","unstructured":"Dini G.; Toletone A.; Sticchi L.; Orsi A.; Bragazzi N.L.; Durando P.; Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature. Hum Vaccin Immunother  2018,14(3),772-789","journal-title":"Hum Vaccin Immunother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3390\/ijerph19053018","volume":"19","author":"\u015awierczy\u0144ska M.","year":"2022","unstructured":"\u015awierczy\u0144ska M.; Mirowska-Guzel D.M.; Pindelska E.; Antiviral drugs in influenza. Int J Environ Res Public Health  2022,19(5),3018","journal-title":"Int J Environ Res Public Health"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"Bouvier N.M.","year":"2008","unstructured":"Bouvier N.M.; Palese P.; The biology of influenza viruses. Vaccine  2008,26(Suppl 4)(4),D49-D53","journal-title":"Vaccine"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0042-6822(87)90026-2","volume":"160","author":"Pritchett T.J.","year":"2022","unstructured":"Pritchett T.J.; Brossmer R.; Rose U.; Paulson J.C.; Recognition of monovalent sialosides by influenza virus H3 hemagglutinin. Virology  2022,160(2),502-506","journal-title":"Virology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fmed.2019.00109","volume":"6","author":"Principi N.","year":"2019","unstructured":"Principi N.; Camilloni B.; Alunno A.; Polinori I.; Argentiero A.; Esposito S.; Drugs for influenza treatment: Is there significant news? Front Med  2019,6,109","journal-title":"Front Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","volume":"39","author":"Lampejo T.","year":"2020","unstructured":"Lampejo T.; Influenza and antiviral resistance: An overview. Eur J Clin Microbiol Infect Dis  2020,39(7),1201-1208","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1039\/D0RA07283D","volume":"11","author":"Mahal A.","year":"2021","unstructured":"Mahal A.; Duan M.; Zinad D.S.; Mohapatra R.K.; Obaidullah A.J.; Wei X.; Pradhan M.K.; Das D.; Kandi V.; Zinad H.S.; Zhu Q.; Recent progress in chemical approaches for the development of novel neuraminidase inhibitors. RSC Advances  2021,11(3),1804-1840","journal-title":"RSC Advances"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/cbdd.12589","volume":"86","author":"Liu S.","year":"2015","unstructured":"Liu S.; Wang W.; Jiang L.; Wan S.; Zhang L.; Yu R.; Jiang T.; 2-Pyridinyl-4(3H)-quinazolinone: A scaffold for anti-influenza A virus compounds. Chem Biol Drug Des  2015,86(5),1221-1225","journal-title":"Chem Biol Drug Des"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1021\/acs.jmedchem.6b00029","volume":"59","author":"Wang P-C.","year":"2016","unstructured":"Wang P-C.; Fang J-M.; Tsai K-C.; Wang S-Y.; Huang W-I.; Tseng Y.C.; Cheng Y.S.; Cheng E.; Cheng T.J.; Cheng R.; Wong C.H.; Peramivir phosphonate derivatives as influenza neuraminidase inhibitors. J Med Chem  2016,59,5297-5310","journal-title":"J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ardp.201500407","volume":"349","author":"Abd El-All A.S.","year":"2016","unstructured":"Abd El-All A.S.; Atta S.M.; Hanaa M.F.; R.; Enas M, A.; Abdalla, M.M. New potent SARS-CoV 3C-like protease inhibitors derived from thieno[2,3-d]-pyrimidine derivatives. Arch Pharm Chem  2016,349,202-210","journal-title":"Arch Pharm Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1016\/j.bmc.2017.07.006","volume":"25","author":"Enkhtaivan G.","year":"2017","unstructured":"Enkhtaivan G.; Muthuraman P.; Kim D.H.; Mistry B.; Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase. Bioorg Med Chem  2017,25(20),5185-5193","journal-title":"Bioorg Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.sjbs.2015.09.005","volume":"24","author":"Mistry B.","year":"2017","unstructured":"Mistry B.; Patel R.V.; Keum Y.S.; Kim D.H.; Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects. Saudi J Biol Sci  2017,24(1),36-44","journal-title":"Saudi J Biol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejmech.2018.01.050","volume":"146","author":"Ju H.","year":"2018","unstructured":"Ju H.; Zhang J.; Sun Z.; Huang Z.; Qi W.; Huang B.; Zhan P.; Liu X.; Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors. Eur J Med Chem  2018,146,220-231","journal-title":"Eur J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ejmech.2016.07.064","volume":"123","author":"Das A.","year":"2016","unstructured":"Das A.; Adak A.K.; Ponnapalli K.; Lin C.H.; Hsu K.C.; Yang J.M.; Hsu T.A.; Lin C.C.; Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors. Eur J Med Chem  2016,123,397-406","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejmech.2015.12.031","volume":"109","author":"Chen B.L.","year":"2016","unstructured":"Chen B.L.; Wang Y.J.; Guo H.; Zeng G.Y.; Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors. Eur J Med Chem  2016,109,199-205","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ardp.201500342","volume":"349","author":"Meng F.J.","year":"2016","unstructured":"Meng F.J.; Sun T.; Dong W.Z.; Li M.H.; Tuo Z.Z.; Discovery of novel pyrazole derivatives as potent neuraminidase inhibitors against influenza H1N1 virus. Arch Pharm  2016,349(3),168-174","journal-title":"Arch Pharm"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1423-0127-17-13","volume":"17","author":"Shih S.R.","year":"2010","unstructured":"Shih S.R.; Chu T.Y.; Reddy G.R.; Tseng S.N.; Chen H.L.; Tang W.F.; Wu M.; Yeh J.Y.; Chao Y.S.; Hsu J.T.A.; Hsieh H.P.; Horng J.T.; Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci  2010,17(1),13","journal-title":"J Biomed Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/07391102.2016.1274271","volume":"36","author":"Sharma G.","year":"2018","unstructured":"Sharma G.; Vasanth Kumar S.; Wahab H.A.; Molecular docking, synthesis, and biological evaluation of naphthoquinone as potential novel scaffold for H5N1 neuraminidase inhibition. J Biomol Struct Dyn  2018,36(1),233-242","journal-title":"J Biomol Struct Dyn"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.tetlet.2016.04.079","volume":"57","author":"Yang Z-L.","year":"2016","unstructured":"Yang Z-L.; Zeng X.; Liu F.; H, P.; Yu, Q.; Meng, X.; Yan, Z.-L.; Fan, Z.-C.; Xiao, H.-X.; Iyer, H.-X.; Yang, Y.; Yu, P. Synthesis of multivalent difluorinated zanamivir analogs as potent antiviral inhibitors. Tetrahedron Lett  2016,57,2579-2582","journal-title":"Tetrahedron Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.bmc.2017.03.052","volume":"25","author":"Li Z.","year":"2017","unstructured":"Li Z.; Meng Y.; Xu S.; Shen W.; Meng Z.; Wang Z.; Ding G.; Huang W.; Xiao W.; Xu J.; Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Bioorg Med Chem  2017,25(10),2772-2781","journal-title":"Bioorg Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1016\/j.bmc.2010.07.028","volume":"18","author":"Weiss S.","year":"2010","unstructured":"Weiss S.; Keller M.; Bernhardt G.; Buschauer A.; K\u00f6nig B.; NG-Acyl-argininamides as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity. Bioorg Med Chem  2010,18(17),6292-6304","journal-title":"Bioorg Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1016\/j.bmcl.2017.11.003","volume":"27","author":"Wang Z.","year":"2017","unstructured":"Wang Z.; Cheng L.P.; Zhang X.H.; Pang W.; Li L.; Zhao J.L.; Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors. Bioorg Med Chem Lett  2017,27(24),5429-5435","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ejmech.2017.10.004","volume":"141","author":"Wang K.","year":"2017","unstructured":"Wang K.; Yang F.; Wang L.; Liu K.; Sun L.; Lin B.; Hu Y.; Wang B.; Cheng M.; Tian Y.; Synthesis and biological evaluation of NH2-acyl oseltamivir analogues as potent neuraminidase inhibitors. Eur J Med Chem  2017,141,648-656","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1007\/s00044-017-2015-6","volume":"26","author":"Xiao M.","year":"2017","unstructured":"Xiao M.; Ye J.; Lian W.; Zhang M.; Li B.; Liu A.; Hu A.; Microwave-assisted synthesis, characterization and bioassay of acylhydrazone derivatives as influenza neuraminidase inhibitors. Med Chem Res  2017,26(12),3216-3227","journal-title":"Med Chem Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1021\/acs.jmedchem.8b00929","volume":"61","author":"Zhang J.","year":"2018","unstructured":"Zhang J.; Poongavanam V.; Kang D.; Bertagnin C.; Lu H.; Kong X.; Ju H.; Lu X.; Gao P.; Tian Y.; Jia H.; Desta S.; Ding X.; Sun L.; Fang Z.; Huang B.; Liang X.; Jia X.; Ma X.; Xu W.; Murugan N.A.; Loregian B.; Zhan P.; Liu X.; Optimization of n-substituted oseltamivir derivatives as potent inhibitors of group-1 and -2 influenza A neuraminidases, including a drug-resistant variant. J Med Chem  2018,61,6379-6397","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejmech.2017.01.039","volume":"128","author":"Neri-Baz\u00e1n R.M.","year":"2017","unstructured":"Neri-Baz\u00e1n R.M.; Garc\u00eda-Machorro J.; M\u00e9ndez-Luna D.; Tolentino-L\u00f3pez L.E.; Mart\u00ednez-Ramos F.; Padilla-Mart\u00ednez I.I.; Aguilar-Faisal L.; Soriano-Urs\u00faa M.A.; Trujillo-Ferrara J.G.; Fragoso-V\u00e1zquez M.J.; Barr\u00f3n B.L.; Correa-Basurto J.; Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1. Eur J Med Chem  2017,128,154-167","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1039\/c6ob02673g","volume":"15","author":"Hajzer V.","year":"2017","unstructured":"Hajzer V.; Fi\u0161era R.; Latika A.; Durmis J.; Koll\u00e1r J.; Frecer V.; Tu\u010dekov\u00e1 Z.; Miertu\u0161 S.; Kostolansk\u00fd F.; Vare\u010dkov\u00e1g E.; \u0160ebesta R.; Stereoisomers of oseltamivir: Synthesis, in silico prediction and biological evaluation. Org Biomol Chem  2017,15,1828-1841","journal-title":"Org Biomol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1038\/s41598-017-07836-y","volume":"7","author":"Vavricka C.J.","year":"2017","unstructured":"Vavricka C.J.; Muto C.; Hasunuma T.\u00b8.; Kimura Y.; Araki M.; Wu Y.; Gao G.F.; Ohrui H.; Izumi M.; Kiyota H.; Synthesis of sulfo-sialic acid analogues: Potent neuraminidase inhibitors in regards to anomeric functionality. Sci Rep  2017,7,8239","journal-title":"Sci Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1016\/j.bmcl.2018.10.040","volume":"28","author":"Cheng L.P.","year":"2018","unstructured":"Cheng L.P.; Wang T.C.; Yu R.; Li M.; Huang J.W.; Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors. Bioorg Med Chem Lett  2018,28(23-24),3622-3629","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.bmcl.2018.09.014","volume":"28","author":"Wang B.","year":"2018","unstructured":"Wang B.; Wang K.; Meng P.; Hu Y.; Yang F.; Liu K.; Lei Z.; Chen B.; Tian Y.; Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors. Bioorg Med Chem Lett  2018,28(21),3477-3482","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1080\/10286020.2018.1509854","volume":"21","author":"Lin D.","year":"2019","unstructured":"Lin D.; Yi Y-J.; Xiao M-W.; Chen J.; Ye J.; Hu A-X.; Lian W-W.; Liu A-L.; Du G-H.; Design, synthesis and biological evaluation of honokiol derivatives as influenza neuraminidase inhibitors. J Asian Nat Prod Res  2019,21,1052-1067","journal-title":"J Asian Nat Prod Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bmc.2017.09.038","volume":"26","author":"Tsuji M.","year":"2018","unstructured":"Tsuji M.; Sriwilaijaroen N.; Inoue H.; Miki K.; Kinoshita K.; Koyama K.; Furuhata K.; Suzuki Y.; Takahashi K.; Synthesis and anti-influenza virus evaluation of triterpene-sialic acid conjugates. Bioorg Med Chem  2018,26(1),17-24","journal-title":"Bioorg Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cmdc.201800092","volume":"13","author":"Hadh\u00e1zi \u00c1.","year":"2018","unstructured":"Hadh\u00e1zi \u00c1.; Li L.; Bailly B.; Maggioni A.; Martin G.; Dirr L.; Dyason J.C.; Thomson R.J.; Gao G.F.; Borb\u00e1s A.; Ve T.; Pascolutti M.; von Itzstein M.; A sulfonozanamivir analogue has potent anti-influenza virus activity. ChemMedChem  2018,13(8),785-789","journal-title":"ChemMedChem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejmech.2019.05.076","volume":"178","author":"Jia R.","year":"2019","unstructured":"Jia R.; Zhang J.; Ai W.; Ding X.; Desta S.; Sun L.; Sun Z.; Ma X.; Li Z.; Wang D.; Huang B.; Zhan P.; Liu X.; Design, synthesis and biological evaluation of \u201cMulti-Site\u201d-binding influenza virus neuraminidase inhibitors. Eur J Med Chem  2019,178,64-80","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1900174","DOI":"10.1002\/ardp.201900174","volume":"353","author":"Cui M.Y.","year":"2020","unstructured":"Cui M.Y.; Xiao M.W.; Xu L.J.; Chen Y.; Liu A.L.; Ye J.; Hu A.X.; Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors. Arch Pharm  2020,353(1),1900174","journal-title":"Arch Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"111635","DOI":"10.1016\/j.ejmech.2019.111635","volume":"182","author":"Ye J.","year":"2019","unstructured":"Ye J.; Yang X.; Xu M.; Chan P.; Ma C.; Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies. Eur J Med Chem  2019,182,111635","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"111940","DOI":"10.1016\/j.ejmech.2019.111940","volume":"187","author":"Ju H.","year":"2020","unstructured":"Ju H.; Xiu S.; Ding X.; Shang M.; Jia R.; Huang B.; Zhan P.; Liu X.; Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. Eur J Med Chem  2020,187,111940","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s00044-019-02343-3","volume":"28","author":"Cui M.Y.","year":"2019","unstructured":"Cui M.Y.; Nie J.X.; Yan Z.Z.; Xiao M.W.; Lin D.; Ye J.; Hu A.X.; Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors. Med Chem Res  2019,28(7),938-947","journal-title":"Med Chem Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/molecules24112176","volume":"24","author":"Hu Y.","year":"2019","unstructured":"Hu Y.; Chen B.; Lei Z.; Zhao H.; Zhu H.; Quan P.; Tian Y.; Synthesis and biological evaluation of nh2-sulfonyl oseltamivir analogues as influenza neuraminidase inhibitors. Molecules  2019,24(11),2176","journal-title":"Molecules"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"112357","DOI":"10.1016\/j.ejmech.2020.112357","volume":"199","author":"Yu Y.","year":"2020","unstructured":"Yu Y.; Qin H.J.; Shi X.X.; Song J.Q.; Zhou J.P.; Yu P.; Fan Z.C.; Zhong M.; Yang Y.; Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection. Eur J Med Chem  2020,199,112357","journal-title":"Eur J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"127839","DOI":"10.1016\/j.bmcl.2021.127839","volume":"37","author":"Zhong Z.J.","year":"2021","unstructured":"Zhong Z.J.; Cheng L.P.; Pang W.; Zheng X.S.; Fu S.K.; Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors. Bioorg Med Chem Lett  2021,37,127839","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"113161","DOI":"10.1016\/j.ejmech.2021.113161","volume":"213","author":"Xiao M.","year":"2021","unstructured":"Xiao M.; Xu L.; Lin D.; Lian W.; Cui M.; Zhang M.; Yan X.; Li S.; Zhao J.; Ye J.; Liu A.; Hu A.; Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. Eur J Med Chem  2021,213,113161","journal-title":"Eur J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/ph14040371","volume":"14","author":"Ye J.","year":"2021","unstructured":"Ye J.; Lin L.; Xu J.; Chan P.K.; Yang X.; Ma C.; Design, synthesis, biological evaluation and In silico studies of pyrazole-based nh2-acyl oseltamivir analogues as potent neuraminidase inhibitors. Pharmaceuticals  2021,14(4),371","journal-title":"Pharmaceuticals"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"116647","DOI":"10.1016\/j.bmc.2022.116647","volume":"57","author":"Yu W.","year":"2022","unstructured":"Yu W.; Ping Cheng L.; Pang, W.; Ling Guo, L. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors. Bioorg Med Chem  2022,57,116647","journal-title":"Bioorg Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"128590","DOI":"10.1016\/j.bmcl.2022.128590","volume":"61","author":"Shi L.","year":"2022","unstructured":"Shi L.; Zhang X.Y.; Cheng L.P.; Design, synthesis and biological evaluation of 1,3,4-triazole-3-acetamide derivatives as potent neuraminidase inhibitors. Bioorg Med Chem Lett  2022,61,128590","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1039\/D2NJ00726F","volume":"46","author":"Zhang X.Y.","year":"2022","unstructured":"Zhang X.Y.; Cheng L.P.; Zhong Z.J.; Pang W.; Song X.; Design, synthesis and biological evaluation of oxalamide derivatives as potent neuraminidase inhibitors. New J Chem  2022,46,13533-13539","journal-title":"New J Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"111841","DOI":"10.1016\/j.ejmech.2019.111841","volume":"185","author":"Wang K.","year":"2020","unstructured":"Wang K.; Lei Z.; Zhao L.; Chen B.; Yang F.; Liu K.; Zhu H.; Zhao H.; Cao R.; Zhang K.; Tian Y.; Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A. Eur J Med Chem  2020,185,111841","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1021\/acsmedchemlett.0c00313","volume":"11","author":"Li M.","year":"2020","unstructured":"Li M.; Cheng L.P.; Pang W.; Zhong Z.J.; Guo L.L.; Design, synthesis, and biological evaluation of novel acylhydrazone derivatives as potent neuraminidase inhibitors. ACS Med Chem Lett  2020,11(9),1745-1750","journal-title":"ACS Med Chem Lett"},{"key":"ref=51a","doi-asserted-by":"publisher","first-page":"e1003223","DOI":"10.1371\/journal.pap.1003223","volume":"9","author":"Walther T.","year":"2013","unstructured":"Walther T.; Karamanska R.; Chan R.W.Y.; Chan M.C.W.; Jia N.; Air G.; Hopton C.; Wong M.P.; Dell A.; Malik Peiris J.S.; Haslam S.M.; Nicholls J.M.; Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog  2013,9,e1003223","journal-title":"PLoS Pathog"},{"key":"ref=51b","doi-asserted-by":"publisher","first-page":"1017338","DOI":"10.3389\/fmolb.2022.1017338","volume":"9","author":"Roy A.","year":"2022","unstructured":"Roy A.; Byrne S.; Sarangi N.K.; Murphy P.V.; Keyes T.E.; A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin. Front Mol Sci  2022,9,1017338","journal-title":"Front Mol Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1128\/JVI.02325-09","volume":"84","author":"Vanderlinden E.","year":"2010","unstructured":"Vanderlinden E.; G\u00f6kta\u015f F.; Cesur, Z.; Froeyen, M.; Reed, M.L.; Russell, C.J.; Cesur, N.; Naesens, L. Novel inhibitors of influenza virus fusion: Structure-activity relationship and interaction with the viral hemagglutinin. J Virol  2010,84(9),4277-4288","journal-title":"J Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/JVI.01225-13","volume":"88","author":"Basu A.","year":"2014","unstructured":"Basu A.; Antanasijevic A.; Wang M.; Li B.; Mills D.M.; Ames J.A.; Nash P.J.; Williams J.D.; Peet N.P.; Moir D.T.; Prichard M.N.; Keith K.A.; Barnard D.L.; Caffrey M.; Rong L.; Bowlin T.L.; New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol  2014,88(3),1447-1460","journal-title":"J Virol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2017.02.040","volume":"130","author":"Zhu Z.","year":"2017","unstructured":"Zhu Z.; Yao Z.; Shen X.; Chen Z.; Liu X.; Parquette J.R.; Liu S.; Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell. Eur J Med Chem  2017,130,185-194","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.2174\/1568026614666141203144551","volume":"14","author":"Torres F.","year":"2014","unstructured":"Torres F.; Brucker N.; Andrade S.; Kawano D.; Garcia S.; Poser G.; Eifler-Lima V.; New insights into the chemistry and antioxidant activity of coumarins. Curr Top Med Chem  2014,14(22),2600-2623","journal-title":"Curr Top Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","volume":"123","author":"Hassan M.Z.","year":"2016","unstructured":"Hassan M.Z.; Osman H.; Ali M.A.; Ahsan M.; Therapeutic potential of coumarins as antiviral agents. Eur J Med Chem  2016,123,236-255","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1016\/j.bmcl.2017.04.091","volume":"27","author":"Khomenko T.M.","year":"2017","unstructured":"Khomenko T.M.; Zarubaev V.V.; Orshanskaya I.R.; Kadyrova R.A.; Sannikova V.A.; Korchagina D.V.; Volcho K.P.; Salakhutdinov N.F.; Anti-influenza activity of monoterpene-containing substituted coumarins. Bioorg Med Chem Lett  2017,27,2920-2925","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1515\/pac-2017-0109","volume":"89","author":"Salakhutdinov N.F.","year":"2017","unstructured":"Salakhutdinov N.F.; Volcho K.P.; Yarovaya O.I.; Monoterpenes as a renewable source of biologically active compounds. Pure Appl Chem  2017,89(8),1105-1117","journal-title":"Pure Appl Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.bmcl.2018.04.057","volume":"28","author":"Ilyina I.V.","year":"2018","unstructured":"Ilyina I.V.; Zarubaev V.V.; Lavrentieva I.N.; Shtro A.A.; Esaulkova I.L.; Korchagina D.V.; Borisevich S.S.; Volcho K.P.; Salakhutdinov N.F.; Highly potent activity of isopulegol-derived substituted octahydro-2-H-chromen-4-ols against influenza A and B viruses. Bioorg Med Chem Lett  2018,28(11),2061-2067","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ejmech.2015.02.029","volume":"93","author":"Song G.","year":"2015","unstructured":"Song G.; Shen X.; Li S.; Li Y.; Liu Y.; Zheng Y.; Lin R.; Fan J.; Ye H.; Liu S.; Structure\u2013activity relationships of 3-O-\u03b2-chacotriosyl ursolic acid derivatives as novel H5N1 entry inhibitors. Eur J Med Chem  2015,93,431-442","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1016\/j.bmc.2019.07.028","volume":"27","author":"Liao Y.","year":"2019","unstructured":"Liao Y.; Chen L.; Li S.; Cui Z.; Lei Z.; Li H.; Liu S.; Song G.; Structure-aided optimization of 3-O-\u03b2-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index. Bioorg Med Chem  2019,27(18),4048-4058","journal-title":"Bioorg Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e1003223","DOI":"10.1371\/journal.ppat.1003223","volume":"9","author":"Walther T.","year":"2013","unstructured":"Walther T.; Karamanska R.; Chan R.W.Y.; Chan M.C.W.; Jia N.; Air G.; Hopton C.; Wong M.P.; Dell A.; Malik Peiris J.S.; Haslam S.M.; Nicholls J.M.; Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog  2013,9(3),e1003223","journal-title":"PLoS Pathog"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biomaterials.2017.05.028","volume":"138","author":"Bhatia S.","year":"2017","unstructured":"Bhatia S.; Lauster D.; Bardua M.; Ludwig K.; Angioletti-Uberti S.; Popp N.; Hoffmann U.; Paulus F.; Budt M.; Stadtm\u00fcller M.; Wolff T.; Hamann A.; B\u00f6ttcher C.; Herrmann A.; Haag R.; Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo. Biomaterials  2017,138,22-34","journal-title":"Biomaterials"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ejmech.2015.12.013","volume":"108","author":"Dong J.","year":"2016","unstructured":"Dong J.; Chen S.; Li R.; Cui W.; Jiang H.; Ling Y.; Yang Z.; Hu W.; Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. Eur J Med Chem  2016,108,605-615","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.antiviral.2017.10.009","volume":"147","author":"Gordon N.A.","year":"2017","unstructured":"Gordon N.A.; McGuire K.L.; Wallentine S.K.; Mohl G.A.; Lynch J.D.; Harrison R.G.; Busath D.D.; Divalent copper complexes as influenza A M2 inhibitors. Antiviral Res  2017,147,100-106","journal-title":"Antiviral Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1016\/j.bmcl.2017.08.062","volume":"27","author":"Suslov E.","year":"2017","unstructured":"Suslov E.; Zarubaev V.V.; Slita A.V.; Ponomarev K.; Korchagina D.; Ayine-Tora D.M.; Reynisson J.; Volcho K.; Salakhutdinov N.; Anti-influenza activity of diazaadamantanes combined with monoterpene moieties. Bioorg Med Chem Lett  2017,27(19),4531-4535","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/cmdc.201500318","volume":"10","author":"Wu S.","year":"2015","unstructured":"Wu S.; Huang J.; Gazzarrini S.; He S.; Chen L.; Li J.; Xing L.; Li C.; Chen L.; Neochoritis C.G.; Liao G.P.; Zhou H.; D\u00f6mling A.; Moroni A.; Wang W.; Isocyanides as influenza a virus subtype H5N1 wild-type m2 channel inhibitors. ChemMedChem  2015,10(11),1837-1845","journal-title":"ChemMedChem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1021\/acsmedchemlett.7b00458","volume":"9","author":"Drakopoulos A.","year":"2018","unstructured":"Drakopoulos A.; Tzitzoglaki C.; McGuire K.; Hoffmann A.; Konstantinidi A.; Kolokouris D.; Ma C.; Freudenberger K.; Hutterer J.; Gauglitz G.; Wang J.; Schmidtke M.; Busath D.D.; Kolocouris A.; Unraveling the binding, proton blockage, and inhibition of influenza M2 wt and S31N by rimantadine variants. ACS Med Chem Lett  2018,9,198-203","journal-title":"ACS Med Chem Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1021\/jm301538e","volume":"56","author":"Wang J.","year":"2013","unstructured":"Wang J.; Ma C.; Wang J.; Jo H.; Canturk B.; Fiorin G.; Pinto L.H.; Lamb R.A.; Klein M.L.; DeGrado W.F.; Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. J Med Chem  2013,56(7),2804-2812","journal-title":"J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","volume":"59","author":"Li F.","year":"2016","unstructured":"Li F.; Ma C.; DeGrado W.F.; Wang J.; Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N Mutant of the influenza a virus M2 proton channel. J Med Chem  2016,59(3),1207-1216","journal-title":"J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","volume":"60","author":"Li F.","year":"2017","unstructured":"Li F.; Hu Y.; Wang Y.; Ma C.; Wang J.; Expeditious lead optimization of isoxazole-containing influenza a virus m2-s31n inhibitors using the suzuki\u2013miyaura cross-coupling reaction. J Med Chem  2017,60(4),1580-1590","journal-title":"J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.3390\/molecules27217370","volume":"27","author":"Peng S.","year":"2022","unstructured":"Peng S.; Progression of antiviral agents targeting viral polymerases. Molecules  2022,27(21),7370","journal-title":"Molecules"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1021\/jm5007275","volume":"57","author":"Clark M.P.","year":"2014","unstructured":"Clark M.P.; Ledeboer M.W.; Davies I.; Byrn R.A.; Jones S.M.; Perola E.; Tsai A.; Jacobs M.; Nti-Addae K.; Bandarage U.K.; Boyd M.J.; Bethiel R.S.; Court J.J.; Deng H.; Duffy J.P.; Dorsch W.A.; Farmer L.J.; Gao H.; Gu W.; Jackson K.; Jacobs D.H.; Kennedy J.M.; Ledford B.; Liang J.; Maltais F.; Murcko M.; Wang T.; Wannamaker M.W.; Bennett H.B.; Leeman J.R.; McNeil C.; Taylor W.P.; Memmott C.; Jiang M.; Rijnbrand R.; Bral C.; Germann U.; Nezami A.; Zhang Y.; Salituro F.G.; Bennani Y.L.; Charifson P.S.; Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. J Med Chem  2014,57(15),6668-6678","journal-title":"J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1021\/acsmedchemlett.6b00487","volume":"8","author":"Bandarage U.K.","year":"2017","unstructured":"Bandarage U.K.; Clark M.P.; Perola E.; Gao H.; Jacobs M.D.; Tsai A.; Gillespie J.; Kennedy J.M.; Maltais F.; Ledeboer M.W.; Davies I.; Gu W.; Byrn R.A.; Addae R.A.; Bennett H.; Leeman J.R.; Jones S.M.; O\u2019Brien C.; Memmott C.; Bennani Y.; Charifson P.S.; Novel 2-substituted 7-azaindole and 7-azaindazole analogues as potential antiviral agents for the treatment of influenza. ACS Med Chem Lett  2017,8,261-265","journal-title":"ACS Med Chem Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1039\/C7OB02085F","volume":"15","author":"Massari S.","year":"2017","unstructured":"Massari S.; Desantis J.; Nannetti G.; Sabatini S.; Tortorella S.; Goracci L.; Cecchetti V.; Loregian A.; Tabarrini O.; Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives. Org Biomol Chem  2017,15(37),7944-7955","journal-title":"Org Biomol Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"113494","DOI":"10.1016\/j.ejmech.2021.113494","volume":"221","author":"Pismataro M.C.","year":"2021","unstructured":"Pismataro M.C.; Felicetti T.; Bertagnin C.; Nizi M.G.; Bonomini A.; Barreca M.L.; Cecchetti V.; Jochmans D.; De Jonghe S.; Neyts J.; Loregian A.; Tabarrini O.; Massari S.; 2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. Eur J Med Chem  2021,221,113494","journal-title":"Eur J Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41423-022-00862-5","volume":"19","author":"Kim C.U.","year":"2022","unstructured":"Kim C.U.; Jeong Y.J.; Lee P.; Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating Toll-like receptor 4 and the NLRP3 inflammasome. Cell Mol Immunol  2022,19(6),715-725","journal-title":"Cell Mol Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"105388","DOI":"10.1016\/j.bioorg.2021.105388","volume":"116","author":"Rogolino D.","year":"2021","unstructured":"Rogolino D.; Naesens L.; Bartoli J.; Carcelli M.; De Luca L.; Pelosi G.; Stokes R.W.; Van Berwaer R.; Vittorio S.; Stevaert A.; Cohen S.M.; Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease. Bioorg Chem  2021,116,105388","journal-title":"Bioorg Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acs.jmedchem.8b01363","volume":"61","author":"Credille C.V.","year":"2018","unstructured":"Credille C.V.; Dick B.L.; Morrison C.N.; Stokes R.W.; Adamek R.N.; Wu N.C.; Wilson I.A.; Cohen S.M.; Structure-activity relationships in metal-binding pharmacophores for influenza endonuclease. J Med Chem  2018,61,10206-10217","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1021\/jm101266s","volume":"54","author":"Jacobsen J.A.","year":"2011","unstructured":"Jacobsen J.A.; Fullagar J.L.; Miller M.T.; Cohen S.M.; Identifying chelators for metalloprotein inhibitors using a fragment-based approach. J Med Chem  2011,54(2),591-602","journal-title":"J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"9438","DOI":"10.1021\/acs.jmedchem.9b00747","volume":"62","author":"Credille C.V.","year":"2019","unstructured":"Credille C.V.; Morrison C.N.; Stokes R.W.; Dick B.L.; Feng Y.; Sun J.; Chen Y.; Cohen S.M.; SAR exploration of tight-binding inhibitors of influenza virus PA endonuclease. J Med Chem  2019,62(21),9438-9449","journal-title":"J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1021\/acs.jmedchem.8b01683","volume":"62","author":"Sethy B.","year":"2019","unstructured":"Sethy B.; Hsieh C.F.; Lin T.J.; Hu P.Y.; Chen Y.L.; Lin C.Y.; Tseng S-N.; Horng J.T.; Hsieh P.W.; Design, synthesis, and biological evaluation of itaconic acid derivatives as potential anti-influenza agents. J Med Chem  2019,62(5),2390-2403","journal-title":"J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ja.2016.80","volume":"70","year":"2017","unstructured":"Sz\u0171cs, Z.; Cs\u00e1v\u00e1s, M.; R\u0151th, E.; Borb\u00e1s, A.; Batta, G.; Perret, F.; Ostorh\u00e1zi, E.; Szatm\u00e1ri, R.; Vanderlinden, E.; Naesens, L.; Herczegh, P. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function. J Antibiot  2017,70(2),152-157","journal-title":"J Antibiot"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/jm900950d","volume":"52","author":"Pint\u00e9r G.","year":"2009","unstructured":"Pint\u00e9r G.; Batta G.; K\u00e9ki S.; M\u00e1ndi A.; Kom\u00e1romi I.; Tak\u00e1cs-Nov\u00e1k K.; Sztaricskai F.; R\u00f6th E.; Ostorh\u00e1zi E.; Rozgonyi F.; Naesens L.; Herczegh P.; Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: An aggregation and receptor binding study. J Med Chem  2009,52(19),6053-6061","journal-title":"J Med Chem"},{"key":"ref=85a","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.1038\/srep14179","volume":"5","author":"Wintachai P.K.","year":"2020","unstructured":"Wintachai P.K.; Lee R.C.; Ramphan S.; Kuadkitkan A.; Wikan N.; Ubol S.; Roytrakul S.; Chu J.J.; Smith D.R.; Activity of andrographolide against chikungunya virus infection. Sci Rep  2020,5,14179","journal-title":"Sci Rep"},{"key":"ref=85b","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00705-016-3166-3","volume":"162","author":"Gupta S.","year":"2017","unstructured":"Gupta S.; Mishra K.P.; Ganju L.; Broad-spectrum antiviral properties of andrographolide. Arch Virol  2017,162,611-623","journal-title":"Arch Virol"},{"key":"ref=85c","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42770-019-00169-0","volume":"51","author":"Majumdar M.","year":"2020","unstructured":"Majumdar M.; Misra T.K.; Roy D.N.; Braz J.; In vitro anti-biofilm activity of 14-deoxy-11,12-didehydroandro-] grapholide from Andrographis paniculata against Pseudomonas aeruginosa. Microbiol  2020,51,15-27","journal-title":"Microbiol"},{"key":"ref=85d","doi-asserted-by":"publisher","first-page":"113710","DOI":"10.1016\/j.ejmech.2021.113710","volume":"224","author":"Zhang H.","year":"2021","unstructured":"Zhang H.; Li S.; Si Y.; XU, H. Andrographolide and its derivatives: Current achievements and future perspectives. Eur J Med Chem  2021,224,113710","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bmcl.2015.12.100","volume":"26","author":"Yuan L.","year":"2016","unstructured":"Yuan L.; Zhang C.; Sun H.; Liu Q.; Huang J.; Sheng L.; Lin B.; Wang J.; Chen L.; The semi-synthesis of novel andrographolide analogues and anti-influenza virus activity evaluation of their derivatives. Bioorg Med Chem Lett  2016,26(3),769-773","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mencom.2016.03.006","volume":"26","author":"Ivanova A.E.","year":"2016","unstructured":"Ivanova A.E.; Burgart Y.V.; Saloutin V.I.; Non-natural nucleosides bearing 4-aryldiazenylpyrazole aglycone. Mendeleev Commun  2016,26(2),106-108","journal-title":"Mendeleev Commun"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.1016\/0040-4020(96)00437-1","volume":"52","author":"Chiacchio U.","year":"1996","unstructured":"Chiacchio U.; Gumina G.; Rescifina A.; Romeo R.; Uccella N.; Casuscelli F.; Piperno A.; Romeo G.; Modified dideoxynucleosides: Synthesis of 2\u2032-N-alkyl-3\u2032-hydroxyalkyl-1\u2032,2\u2032-isoxazolidinyl thymidine and 5-fluorouridine derivatives. Tetrahedron  1996,52(26),8889-8898","journal-title":"Tetrahedron"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"126605","DOI":"10.1016\/j.bmcl.2019.08.009","volume":"29","author":"Li G.","year":"2019","unstructured":"Li G.; Obul M.; Zhao J.; Liu G.; Lu W.; Aisa H.A.; Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents. Bioorg Med Chem Lett  2019,29(19),126605","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"103733","DOI":"10.1016\/j.bioorg.2020.103733","volume":"98","author":"Lamuta A.","year":"2020","unstructured":"Lamuta A.; Naesens L.; Liekens S.; Lillsunde K-E.; Tammela P.; Kikelja D.; Toma\u0161i\u010d T. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90. Bioorg Chem  2020,98,103733","journal-title":"Bioorg Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1021\/acs.jmedchem.6b00864","volume":"59","author":"Gjorgjieva M.","year":"2016","unstructured":"Gjorgjieva M.; Toma\u0161i\u010d T.; Baran\u010dokova M.; Katsamakas S.; Ila\u0161 J.; Tammela P.; Peterlin Ma\u0161i\u010d L.; Kikelj D.;  Discovery of benzothiazole scaffold-based dna gyrase b inhibitors. J Med Chem  2016,59(19),8941-8954","journal-title":"J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"104958","DOI":"10.1016\/j.bioorg.2021.104958","volume":"112","author":"Apayd\u0131n \u00c7.B.","year":"2021","unstructured":"Apayd\u0131n \u00c7.B.; Tansuyu M.; Cesur Z.; Naesens L.; G\u00f6kta\u015f F.; Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones. Bioorg Chem  2021,112,104958","journal-title":"Bioorg Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S105473","volume":"10","author":"Hussain M.","year":"2017","unstructured":"Hussain M.; Galvin H.; Haw T.Y.; Nutsford A.; Husain M.; Drug resistance in influenza A virus: The epidemiology and management. Infect Drug Resist  2017,10,121-134","journal-title":"Infect Drug Resist"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.virol.2018.08.011","volume":"524","author":"Zarubaev V.V.","year":"2018","unstructured":"Zarubaev V.V.; Pushkina E.A.; Borisevich S.S.; Galochkina A.V.; Garshinina A.V.; Shtro A.A.; Egorova A.A.; Sokolova A.S.; Khursan S.L.; Yarovaya O.I.; Salakhutdinov N.F.; Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity. Virology  2018,524,69-77","journal-title":"Virology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/fcp.12750","volume":"36","author":"Zarubaev V.V.","year":"2022","unstructured":"Zarubaev V.V.; Garshinina A.V.; Volobueva A.S.; Slita A.V.; Yarovaya O.I.; Bykov V.V.; Leonov K.A.; Motov V.S.; Khazanov V.A.; Salakhutdinov N.F.; Optimization of application schedule of camphecene, a novel anti-influenza compound, based on its pharmacokinetic characteristics. Fundam Clin Pharmacol  2022,36(3),518-525","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jep.2011.11.056","volume":"139","author":"Wu Q.","year":"2012","unstructured":"Wu Q.; Wang W.; Dai X.; Wang Z.; Shen Z.; Ying H.; Yu C.; Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera. J Ethnopharmacol  2012,139(2),668-671","journal-title":"J Ethnopharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.3390\/molecules27123718","volume":"27","author":"Madia V.N.","year":"2022","unstructured":"Madia V.N.; Toscanelli W.; De Vita D.; De Angelis M.; Messore A.; Longo D.; Scipione L.; Tudino V.; Diodata D\u2019 A.; Di Santo R.; Garzoli S.; Stringaro A.; Colone M.; Marchetti M.; Superti F.; Nencioni L.; Costi R.; Ultrastructural damages to H1N1 Influenza virus caused by vapor essential oils. Molecules  2022,27,3718","journal-title":"Molecules"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230907093501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220784\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230907093501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T10:19:13Z","timestamp":1715077153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220784\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":101,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230907093501","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}